YI
111, Inc.
NASDAQ · Healthcare · Medical - Pharmaceuticals · CN
$3.60
+1.69%Margins
Gross margin
5.7%
EBITDA margin
-0.4%
EBIT margin
-0.5%
Net margin
-0.9%
FCF margin
1.1%
83.1%
Return on equity
-5.3%
Return on assets
68.8%
Return on invested capital
10.09x
Asset turnover
$17.8M
Cash from operations
$0.89
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026